Shuttle Pharmaceuticals Holdings (SHPH) Enterprise Value (2021 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) posted quarterly Enterprise Value of -$1.1 million for Q1 2026, up 76.44% year-over-year from -$602326.9 in Q1 2025, and down 312.0% quarter-over-quarter from -$257955.0 in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Enterprise Value (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Enterprise Value history runs 6 years deep, the most recent figure standing at -$1.1 million for Q1 2026.
- In Q1 2026, Enterprise Value rose 76.44% year-over-year to -$1.1 million; the TTM figure through Mar 2026 stood at -$1.1 million (up 76.44% YoY), while the FY2025 annual figure was -$257955.0, up 86.57% from the prior year.
- Enterprise Value for Q1 2026 stood at -$1.1 million, down from -$257955.0 in the prior quarter.
- The five-year high for Enterprise Value was -$156656.0 in Q3 2024, with the low at -$9.1 million in Q3 2022.
- The 5-year median for Enterprise Value is -$4.5 million (2025), against an average of -$4.2 million.
- The sharpest annual moves came in 2022 and 2024: Enterprise Value slumped 6191.01% in 2022, then soared 97.29% in 2024.
- Shuttle Pharmaceuticals Holdings' Enterprise Value stood at -$5.4 million in 2022, then declined by 0.97% to -$5.5 million in 2023, then soared by 64.86% to -$1.9 million in 2024, then surged by 86.57% to -$257955.0 in 2025, then plunged by 312.0% to -$1.1 million in 2026.
- Business Quant data shows SHPH's Enterprise Value at -$1.1 million in Q1 2026, -$257955.0 in Q4 2025, and -$2.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | -164.00 Mn |
| 10 | Shuttle Pharmaceuticals Holdings | 1.89 Mn | 1.89 Mn | - | -1.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.06 Mn |
| Dec 31, 2025 | -257,955.00 |
| Sep 30, 2025 | -2.09 Mn |
| Jun 30, 2025 | -4.74 Mn |
| Mar 31, 2025 | -4.51 Mn |
| Dec 31, 2024 | -1.92 Mn |
| Sep 30, 2024 | -156,656.00 |
| Jun 30, 2024 | -2.25 Mn |
| Mar 31, 2024 | -3.15 Mn |
| Dec 31, 2023 | -5.46 Mn |
| Sep 30, 2023 | -5.79 Mn |
| Jun 30, 2023 | -8.35 Mn |
| Mar 31, 2023 | -9.10 Mn |
| Dec 31, 2022 | -5.41 Mn |
| Sep 30, 2022 | -9.12 Mn |
| Dec 31, 2021 | -504,749.00 |
| Sep 30, 2021 | -144,975.00 |